AFG2A-related encephalopathy: Effectiveness of ketogenic diet in epilepsy and mitochondrial dynamics modulation
- 19 July 2025
- journal article
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 58, 20-26
Abstract
No abstract availableKeywords
Funding Information
- Department of Health (PFP00201-PERIS)
- Generalitat de Catalunya
- Carlos III Health Institute (FI21/0073)
This publication has 18 references indexed in Scilit:
- The SPATA5-SPATA5L1 ATPase complex directs replisome proteostasis to ensure genome integrityCell, 2024
- Labeling of heterochronic ribosomes reveals C1ORF109 and SPATA5 control a late step in human ribosome assemblyCell Reports, 2022
- The ketogenic diet as a therapeutic intervention strategy in mitochondrial diseaseThe International Journal of Biochemistry & Cell Biology, 2021
- The role of recessive inheritance in early-onset epileptic encephalopathies: a combined whole-exome sequencing and copy number studyEuropean Journal of Human Genetics, 2018
- Cognitive benefits of the ketogenic diet in patients with epilepsy: A systematic overviewEpilepsy & Behavior, 2018
- A Ketogenic Diet Improves Mitochondrial Biogenesis and Bioenergetics via the PGC1α-SIRT3-UCP2 AxisNeurochemical Research, 2018
- Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study GroupEpilepsia Open, 2018
- Compound heterozygous SPATA5 variants in four families and functional studies of SPATA5 deficiencyEuropean Journal of Human Genetics, 2018
- Isolated Hearing Impairment Caused by SPATA5 Mutations in a Family with Variable Phenotypic Expression2017
- The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trialThe Lancet Neurology, 2008